Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 434052, 12 pages
http://dx.doi.org/10.1155/2015/434052
Research Article

Plant Natural Products Calycosin and Gallic Acid Synergistically Attenuate Neutrophil Infiltration and Subsequent Injury in Isoproterenol-Induced Myocardial Infarction: A Possible Role for Leukotriene B4 12-Hydroxydehydrogenase?

1School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pok Fu Lam, Hong Kong
2Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pok Fu Lam, Hong Kong
3Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, 10-102 Clinical Sciences Building, University of Alberta, Edmonton, Alberta, Canada T6G 2G3

Received 2 May 2015; Revised 16 June 2015; Accepted 24 June 2015

Academic Editor: Yung-Hsiang Chen

Copyright © 2015 Yuanyuan Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. O. Bonow, L. A. Smaha, S. C. Smith Jr., G. A. Mensah, and C. Lenfant, “World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic,” Circulation, vol. 106, no. 13, pp. 1602–1605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1074–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Jordan, Z.-Q. Zhao, and J. Vinten-Johansen, “The role of neutrophils in myocardial ischemia-reperfusion injury,” Cardiovascular Research, vol. 43, no. 4, pp. 860–878, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Litt, R. W. Jeremy, H. F. Weisman, J. A. Winkelstein, and L. C. Becker, “Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury,” Circulation, vol. 80, no. 6, pp. 1816–1827, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. S. R. Jolly, W. J. Kane, B. G. Hook, G. D. Abrams, S. L. Kunkel, and B. R. Lucchesi, “Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion,” American Heart Journal, vol. 112, no. 4, pp. 682–690, 1986. View at Publisher · View at Google Scholar · View at Scopus
  6. R. L. Engler, “Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion,” The American Journal of Cardiology, vol. 63, no. 10, pp. E19–E23, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. A. W. Ford-Hutchinson, M. A. Bray, M. V. Doig, M. E. Shipley, and M. J. H. Smith, “Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes,” Nature, vol. 286, no. 5770, pp. 264–265, 1980. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Hammarstrom, “Leukotrienes,” Annual Review of Biochemistry, vol. 52, pp. 355–377, 1983. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Yokomizo, T. Izumi, and T. Shimizu, “Leukotriene B4: metabolism and signal transduction,” Archives of Biochemistry and Biophysics, vol. 385, no. 2, pp. 231–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Hakonarson, S. Thorvaldsson, A. Helgadottir et al., “Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial,” Journal of the American Medical Association, vol. 293, no. 18, pp. 2245–2256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Werz and D. Steinhilber, “Therapeutic options for 5-lipoxygenase inhibitors,” Pharmacology & Therapeutics, vol. 112, no. 3, pp. 701–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. C. S. Bitencourt, V. L. Bessi, D. N. Huynh et al., “Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury,” Journal of Cellular and Molecular Medicine, vol. 17, no. 12, pp. 1554–1565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. F. M. Williams, “Neutrophils and myocardial reperfusion injury,” Pharmacology and Therapeutics, vol. 72, no. 1, pp. 1–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-H. Tai, C. M. Ensor, M. Tong, H. Zhou, and F. Yan, “Prostaglandin catabolizing enzymes,” Prostaglandins and Other Lipid Mediators, vol. 68-69, pp. 483–493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Primiano, Y. Li, T. W. Kensler, M. A. Trush, and T. R. Sutter, “Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention,” Carcinogenesis, vol. 19, no. 6, pp. 999–1005, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Yokomizo, T. Izumi, T. Takahashi et al., “Enzymatic inactivation of leukotriene B4 by a novel enzyme found in the porcine kidney. Purification and properties of leukotriene B4 12-hydroxydehydrogenase,” The Journal of Biological Chemistry, vol. 268, no. 24, pp. 18128–18135, 1993. View at Google Scholar · View at Scopus
  17. C. B. Clish, B. D. Levy, N. Chiang, H.-H. Tai, and C. N. Serhan, “Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-oxoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation,” The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25372–25380, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhao, C.-C. Weng, M. Tong, J. Wei, and H.-H. Tai, “Restoration of leukotriene B4-12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo,” Lung Cancer, vol. 68, no. 2, pp. 161–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Dick, M.-K. Kwak, T. R. Sutter, and T. W. Kensler, “Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 40803–40810, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Wube, E.-M. Wenzig, S. Gibbons, K. Asres, R. Bauer, and F. Bucar, “Constituents of the stem bark of Discopodium penninervium and their LTB4 and COX-1 and -2 inhibitory activities,” Phytochemistry, vol. 69, no. 4, pp. 982–987, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kumar, K. Ziereis, W. Wiegrebe, and K. Müller, “Medicinal plants from Nepal: evaluation as inhibitors of leukotriene biosynthesis,” Journal of Ethnopharmacology, vol. 70, no. 3, pp. 191–195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Sumner, U. Salan, D. W. Knight, and J. R. S. Hoult, “Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components,” Biochemical Pharmacology, vol. 43, no. 11, pp. 2313–2320, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Rong, R. Tilton, J. Shen et al., “Genome-wide biological response fingerprinting (BioReF) of the Chinese botanical formulation ISF-1 enables the selection of multiple marker genes as a potential metric for quality control,” Journal of Ethnopharmacology, vol. 113, no. 1, pp. 35–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Wei, J. Liu, X. C. Le et al., “Pharmacological induction of leukotriene B4-12-hydroxydehydrogenase suppresses the oncogenic transformation of human hepatoma HepG2 cells,” International Journal of Oncology, vol. 39, no. 3, pp. 735–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Clark and W. M. Nauseef, “Isolation and functional analysis of neutrophils,” Current Protocols in Immunology, chapter 7, unit 7.23, 2001. View at Google Scholar
  26. T. N. Khatua, R. Padiya, S. Karnewar et al., “Garlic provides protection to mice heart against isoproterenol-induced oxidative damage: role of nitric oxide,” Nitric Oxide, vol. 27, no. 1, pp. 9–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Gupta, A. Kanwal, U. K. Putcha et al., “Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: a new therapeutic implication,” Journal of Translational Medicine, vol. 11, article 80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. N. Goyal, S. Arora, A. K. Sharma et al., “Preventive effect of crocin of Crocus sativus on hemodynamic, biochemical, histopathological and ultrastuctural alterations in isoproterenol-induced cardiotoxicity in rats,” Phytomedicine, vol. 17, no. 3-4, pp. 227–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. T. Jørgensen, “A challenging drug development process in the era of personalized medicine,” Drug Discovery Today, vol. 16, no. 19-20, pp. 891–897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Csermely, V. Ágoston, and S. Pongor, “The efficiency of multi-target drugs: the network approach might help drug design,” Trends in Pharmacological Sciences, vol. 26, no. 4, pp. 178–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-Y. Zhang, “One-compound-multiple-targets strategy to combat Alzheimer's disease,” FEBS Letters, vol. 579, no. 24, pp. 5260–5264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Chakraborti, A. Mandal, M. Mandal, S. Das, and S. Chakraborti, “Complement activation in heart diseases. Role of oxidants,” Cellular Signalling, vol. 12, no. 9-10, pp. 607–617, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Carbone, A. Nencioni, F. Mach, N. Vuilleumier, and F. Montecucco, “Pathophysiological role of neutrophils in acute myocardial infarction,” Thrombosis and Haemostasis, vol. 110, no. 3, pp. 501–514, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. W. H. Barry, “Mechanisms of immune-mediated myocyte injury,” Circulation, vol. 89, no. 5, pp. 2421–2432, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Borgeat and P. H. Naccache, “Biosynthesis and biological activity of leukotriene B4,” Clinical Biochemistry, vol. 23, no. 5, pp. 459–468, 1990. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Helgadottir, A. Manolescu, A. Helgason et al., “A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction,” Nature Genetics, vol. 38, no. 1, pp. 68–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Lavine, S. Epelman, K. Uchida et al., “Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 45, pp. 16029–16034, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Abe, Y. Takiguchi, S. Ichimaru, S. Kaji, K. Tsuchiya, and K. Wada, “Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method,” European Journal of Pharmacology, vol. 589, no. 1–3, pp. 215–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Ojha, S. Goyal, C. Sharma, S. Arora, S. Kumari, and D. S. Arya, “Cardioprotective effect of lycopene against isoproterenol-induced myocardial infarction in rats,” Human and Experimental Toxicology, vol. 32, no. 5, pp. 492–503, 2013. View at Publisher · View at Google Scholar · View at Scopus